KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northrop Grumman (NOC) Common Equity (2016 - 2026)

Northrop Grumman (NOC) has disclosed Common Equity for 18 consecutive years, with $17.1 billion as the latest value for Q1 2026.

  • For Q1 2026, Common Equity rose 14.22% year-over-year to $17.1 billion; the TTM value through Mar 2026 reached $17.1 billion, up 14.22%, while the annual FY2025 figure was $16.7 billion, N/A changed from the prior year.
  • Common Equity was $17.1 billion for Q1 2026 at Northrop Grumman, up from $16.7 billion in the prior quarter.
  • The five-year high for Common Equity was $17.1 billion in Q1 2026, with the low at -$153.0 million in Q4 2022.
  • Historically, Common Equity has averaged $10.8 billion across 5 years, with a median of $14.5 billion in 2024.
  • The largest annual shift saw Common Equity surged 165862.5% in 2022 before it tumbled 98.86% in 2023.
  • Over 5 years, Common Equity stood at -$153.0 million in 2022, then soared by 9769.93% to $14.8 billion in 2023, then decreased by 0.32% to $14.7 billion in 2024, then rose by 13.06% to $16.7 billion in 2025, then grew by 2.64% to $17.1 billion in 2026.
  • Per Business Quant database, its latest 3 readings for Common Equity were $17.1 billion in Q1 2026, $16.7 billion in Q4 2025, and $16.0 billion in Q3 2025.